{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:55:55Z","timestamp":1790506555633,"version":"4.1.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00395","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:01:07Z","timestamp":1588914067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":120,"title":["Clinical and Imaging Markers of Prodromal Parkinson's Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Eldbj\u00f8rg","family":"Hustad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan O.","family":"Aasly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/nedt.2007.3.1.145","article-title":"Prodromal non-motor symptoms of Parkinson's disease","volume":"3","author":"Pellicano","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol Neurobiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson's disease","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"J Parkinson's Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JPD-191592","article-title":"Functional connectivity signatures of Parkinson's disease","volume":"9","author":"Tessitore","year":"2019","journal-title":"J Parkinson's Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ejn.14269","article-title":"The prodromes of Parkinson's disease","volume":"49","author":"Rees","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0175424","DOI":"10.1371\/journal.pone.0175424","article-title":"DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers","volume":"12","author":"Artzi","year":"2017","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]","volume":"9","author":"Iranzo","year":"2010","journal-title":"Lancet Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00702-018-1910-4","article-title":"Diagnostic biomarkers for Parkinson's disease at a glance: where are we?","volume":"125","author":"Cova","year":"2018","journal-title":"J Neural Transm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal Parkinson's disease: the decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Mov Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","article-title":"Development of the university of pennsylvania smell identification test: a standardized microencapsulated test of olfactory function","volume":"32","author":"Doty","year":"1984","journal-title":"Physiol Behav"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3753786","article-title":"Hyposmia as a predictive marker of parkinson's disease: a systematic review and meta-analysis","volume":"2019","author":"Sui","year":"2019","journal-title":"BioMed Res Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nicl.2017.04.011","article-title":"Neuroimaging in pre-motor Parkinson's disease","volume":"15","author":"Barber","year":"2017","journal-title":"NeuroImage Clin"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2157","DOI":"10.1212\/WNL.0000000000008567","article-title":"Physical activity and prodromal features of Parkinson disease","volume":"93","author":"Hughes","year":"2019","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/jamaneurol.2017.4243","article-title":"When Do alpha-Synucleinopathies Start? An epidemiological timeline: a review","volume":"75","author":"Savica","year":"2018","journal-title":"JAMA Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp.2009.183715","article-title":"Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease","volume":"81","author":"Ponsen","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fneur.2019.00621","article-title":"Severe constipation in Parkinson's disease and in Parkinsonisms: prevalence and affecting factors","volume":"10","author":"Frazzitta","year":"2019","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/ene.13082","article-title":"Constipation: an emerging risk factor for Parkinson's disease?","volume":"23","author":"Stirpe","year":"2016","journal-title":"Eur J Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding Parkinson's disease: a systematic review and meta-analysis","volume":"87","author":"Adams-Carr","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson's disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/aje\/kwr119","article-title":"A prospective study of bowel movement frequency and risk of Parkinson's disease","volume":"174","author":"Gao","year":"2011","journal-title":"Am J Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9421098","DOI":"10.1155\/2018\/9421098","article-title":"REM sleep behavior disorder (RBD) in dementia with lewy bodies (DLB)","volume":"2018","author":"Chan","year":"2018","journal-title":"Behav Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JPD-191627","article-title":"Sleep disturbance as potential risk and progression factor for Parkinson's disease","volume":"9","author":"Bohnen","year":"2019","journal-title":"J Parkinson's Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fneur.2018.00376","article-title":"Accuracy of rating scales and clinical measures for screening of rapid eye movement sleep behavior disorder and for predicting conversion to Parkinson's disease and other synucleinopathies","volume":"9","author":"Skorvanek","year":"2018","journal-title":"Front Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mds.26989","article-title":"Validation of the MDS research criteria for prodromal Parkinson's disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort","volume":"32","author":"Fereshtehnejad","year":"2017","journal-title":"Mov Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11940-017-0458-1","article-title":"Sleep disturbances in the prodromal stage of parkinson disease","volume":"19","author":"Al-Qassabi","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/aje\/kwq478","article-title":"Daytime napping, nighttime sleeping, and Parkinson disease","volume":"173","author":"Gao","year":"2011","journal-title":"Am J Epidemiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fneur.2018.01191","article-title":"The Parkinsonian personality: more than just a \u201cTrait\u201d","volume":"9","author":"Luca","year":"2018","journal-title":"Front Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/mds.23230","article-title":"Anxious personality predicts an increased risk of Parkinson's disease","volume":"25","author":"Bower","year":"2010","journal-title":"Mov Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Depression and Parkinson's disease: current knowledge","volume":"13","author":"Marsh","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson's disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson disease: a nationwide cohort study","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: a register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Mov Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord"},{"key":"B45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/brain\/aww291","article-title":"Trajectories of prediagnostic functioning in Parkinson's disease","volume":"140","author":"Darweesh","year":"2017","journal-title":"Brain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaneurol.2017.2248","article-title":"Association between poor cognitive functioning and risk of incident Parkinsonism: the rotterdam study","volume":"74","author":"Darweesh","year":"2017","journal-title":"JAMA Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mds.27616","article-title":"Predicting diagnosis of Parkinson's disease: a risk algorithm based on primary care presentations","volume":"34","author":"Schrag","year":"2019","journal-title":"Mov Disord"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/mds.27189","article-title":"Cognition and the course of prodromal Parkinson's disease","volume":"32","author":"Weintraub","year":"2017","journal-title":"Mov Disord"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamaneurol.2018.2248","article-title":"Orthostatic hypotension as a prodromal marker of \u03b1-Synucleinopathies","volume":"75","author":"Palma","year":"2018","journal-title":"JAMA Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"Natural history of pure autonomic failure: A United States prospective cohort","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Ann Neurol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6303945","DOI":"10.1155\/2019\/6303945","article-title":"Erectile dysfunction preceding clinically diagnosed alpha-synucleinopathies: a case-control study in olmsted county","volume":"2019","author":"Hasan","year":"2019","journal-title":"Parkinson's Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/aje\/kwm246","article-title":"Erectile function and risk of Parkinson's disease","volume":"166","author":"Gao","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov Disord"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson's disease in primary care: a case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.25122","article-title":"Calibration of unified Parkinson's disease rating scale scores to movement disorder society-unified Parkinson's disease rating scale scores","volume":"27","author":"Goetz","year":"2012","journal-title":"Mov Disord"},{"key":"B57","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson's disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/aje\/kwp033","article-title":"Plasma urate and Parkinson's disease in the atherosclerosis risk in communities (ARIC) study","volume":"169","author":"Chen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","article-title":"Prospective study of plasma urate and risk of Parkinson disease in men and women","volume":"86","author":"Gao","year":"2016","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.27897","article-title":"CSF or serum neurofilament light added to alpha-Synuclein panel discriminates Parkinson's from controls","volume":"35","author":"Oosterveld","year":"2020","journal-title":"Mov Disord"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"Longitudinal analyses of cerebrospinal fluid alpha-Synuclein in prodromal and early Parkinson's disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0000000000003989","article-title":"Skin nerve phosphorylated \u03b1-synuclein deposits in idiopathic REM sleep behavior disorder","volume":"88","author":"Antelmi","year":"2017","journal-title":"Neurology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/mds.27044","article-title":"Peripheral synucleinopathy in early Parkinson's disease: submandibular gland needle biopsy findings","volume":"32","author":"Adler","year":"2017","journal-title":"Mov Disord"},{"key":"B66","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1474-4422(16)00080-6","article-title":"Assessment of alpha-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study","volume":"15","author":"Vilas","year":"2016","journal-title":"Lancet Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/WNL.0000000000004185","article-title":"Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease","volume":"89","author":"Sierra","year":"2017","journal-title":"Neurology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder","volume":"135","author":"Postuma","year":"2012","journal-title":"Brain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/mds.26754","article-title":"Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression","volume":"31","author":"Majbour","year":"2016","journal-title":"Mov Disord"},{"key":"B70","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov Disord"},{"key":"B71","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am J Pathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.parkreldis.2018.01.018","article-title":"Evolution of cerebrospinal fluid total alpha-synuclein in Parkinson's disease","volume":"49","author":"Forland","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"B73","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","article-title":"The prediagnostic phase of Parkinson's disease","volume":"87","author":"Noyce","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ene.12753","article-title":"Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature","volume":"23","author":"Schneider","year":"2016","journal-title":"Eur J Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/nan.12486","article-title":"Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease","volume":"44","author":"Ruffmann","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JPD-191630","article-title":"What Have We Learned from cerebrospinal fluid studies about biomarkers for detecting LRRK2 Parkinson's disease patients and healthy subjects with Parkinson's-associated LRRK2 mutations?","volume":"9","author":"Loeffler","year":"2019","journal-title":"J Parkinson's Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.3233\/JPD-181457","article-title":"From prodromal to overt Parkinson's disease: towards a new definition in the year 2040","volume":"8","author":"Berg","year":"2018","journal-title":"J Parkinson's Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/mds.25430","article-title":"The VPS35 gene and Parkinson's disease","volume":"28","author":"Deng","year":"2013","journal-title":"Mov Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00702-014-1179-1","article-title":"VPS35 Parkinson's disease phenotype resembles the sporadic disease","volume":"121","author":"Struhal","year":"2014","journal-title":"J Neural Transm"},{"key":"B80","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.20456","article-title":"Clinical features of LRRK2-associated Parkinson's disease in central Norway","volume":"57","author":"Aasly","year":"2005","journal-title":"Ann Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1212\/WNL.0000000000000675","article-title":"LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance","volume":"83","author":"Hentati","year":"2014","journal-title":"Neurology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/mds.27342","article-title":"Application of the movement disorder society prodromal criteria in healthy G2019S-LRRK2 carriers","volume":"33","author":"Mirelman","year":"2018","journal-title":"Mov Disord"},{"key":"B83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2015.09.007","article-title":"Neuroimaging of Parkinson's disease: expanding views","volume":"59","author":"Weingarten","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"B84","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson's disease","volume":"10","author":"He","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnagi.2019.00057","article-title":"The Combination of DAT-SPECT, structural and diffusion MRI predicts clinical progression in Parkinson's disease","volume":"11","author":"Lorio","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","article-title":"Imaging prodromal Parkinson disease: the Parkinson associated risk syndrome study","volume":"83","author":"Jennings","year":"2014","journal-title":"Neurology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study","volume":"10","author":"Iranzo","year":"2011","journal-title":"Lancet Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/sleep\/26.5.507","article-title":"Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls","volume":"26","author":"Eisensehr","year":"2003","journal-title":"Sleep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1016\/j.neurobiolaging.2015.08.025","article-title":"Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?","volume":"36","author":"Arnaldi","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B90","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1148\/radiol.2017162486","article-title":"Loss of substantia nigra hyperintensity at 3.0-T MR imaging in idiopathic REM sleep behavior disorder: comparison with (123)I-FP-CIT SPECT","volume":"287","author":"Bae","year":"2018","journal-title":"Radiology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1212\/WNL.0b013e31828250d6","article-title":"Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease","volume":"80","author":"Sierra","year":"2013","journal-title":"Neurology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/mds.23356","article-title":"Dopamine turnover increases in asymptomatic LRRK2 mutations carriers","volume":"25","author":"Sossi","year":"2010","journal-title":"Mov Disord"},{"key":"B93","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1474-4422(17)30056-X","article-title":"Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies","volume":"16","author":"Wile","year":"2017","journal-title":"Lancet Neurol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","article-title":"The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study","volume":"17","author":"Liu","year":"2018","journal-title":"Lancet Neurol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT-a clinical comparison","volume":"8","author":"Jakobson Mo","year":"2018","journal-title":"EJNMMI Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nicl.2017.08.003","article-title":"Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's disease","volume":"16","author":"Dayan","year":"2017","journal-title":"NeuroImage Clin"},{"key":"B97","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","article-title":"In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study","volume":"17","author":"Knudsen","year":"2018","journal-title":"Lancet Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2017.09.019","article-title":"Structural connectome alterations in prodromal and de novo Parkinson's disease patients","volume":"45","author":"Wen","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1002\/mds.23265","article-title":"Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease","volume":"25","author":"Aasly","year":"2010","journal-title":"Mov Disord"},{"key":"B100","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.parkreldis.2010.05.005","article-title":"Genealogical studies in LRRK2-associated Parkinson's disease in central Norway","volume":"16","author":"Johansen","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.26674","article-title":"Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community","volume":"31","author":"Mahlknecht","year":"2016","journal-title":"Mov Disord"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/mds.27349","article-title":"Age- and sex-related heterogeneity in prodromal Parkinson's disease","volume":"33","author":"Heinzel","year":"2018","journal-title":"Mov Disord"},{"key":"B106","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1007\/s00415-018-8969-6","article-title":"The accuracy of the clinical diagnosis of Parkinson disease. The HUNT study","volume":"265","author":"Hustad","year":"2018","journal-title":"J Neurol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/mds.27035","article-title":"Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts","volume":"32","author":"Pilotto","year":"2017","journal-title":"Mov Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:01:08Z","timestamp":1588914068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":108,"alternative-id":["10.3389\/fneur.2020.00395"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00395","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"395"}}